Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection
Philippe Karoyan, Vincent Vieillard, Luis Gómez‐Morales, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 382
Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation
Bahaa Jawad, Puja Adhikari, Rudolf Podgornik, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4425-4441
Open Access | Times Cited: 128
Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
Chen Fu, Lifeng Yu, Yuxi Miao, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 498-516
Open Access | Times Cited: 106
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Gavin Y. Oudit, Kaiming Wang, Anissa Viveiros, et al.
Cell (2023) Vol. 186, Iss. 5, pp. 906-922
Open Access | Times Cited: 74
Machine learning for functional protein design
Pascal Notin, Nathan Rollins, Yarin Gal, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 2, pp. 216-228
Closed Access | Times Cited: 72
A Global Picture: Therapeutic Perspectives for COVID-19
Vivek P. Chavda, Carron Kapadia, Shailvi Soni, et al.
Immunotherapy (2022) Vol. 14, Iss. 5, pp. 351-371
Open Access | Times Cited: 71
Forensic and Pharmaceutical Risks in the Organization of Pharmacotherapy of Covid, Post-Covid and Long-Covid Disorders. COVID-19 and Vaccination Practice Standards.
Вікторія Шаповалова
SSP Modern Pharmacy and Medicine (2022) Vol. 2, Iss. 4, pp. 1-24
Open Access | Times Cited: 69
Advances in developing ACE2 derivatives against SARS-CoV-2
Haoran Zhang, Panjing Lv, Jingrui Jiang, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e369-e378
Open Access | Times Cited: 38
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
Lin Wang, Yan Wu, Sheng Yao, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 4, pp. 788-796
Open Access | Times Cited: 57
Recent Progress in Development and Application of DNA, Protein, Peptide, Glycan, Antibody, and Aptamer Microarrays
G. M. Aparna, Kishore K. R. Tetala
Biomolecules (2023) Vol. 13, Iss. 4, pp. 602-602
Open Access | Times Cited: 26
Antiviral fibrils of self-assembled peptides with tunable compositions
Joseph Dodd‐o, Abhishek Roy, Zain Siddiqui, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?
Stanislav R. Kurpe, Sergei Y. Grishin, Alexey K. Surin, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9552-9552
Open Access | Times Cited: 54
Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury
Murat Öz, Dietrich E. Lorke
Biomedicine & Pharmacotherapy (2021) Vol. 136, pp. 111193-111193
Open Access | Times Cited: 52
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
Lennox Chitsike, Penelope J. Duerksen-Hughes
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 41
Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
Md Minhas Hossain Sakib, Aktiya Anjum Nishat, Mohammad Tarequl Islam, et al.
Computers in Biology and Medicine (2021) Vol. 136, pp. 104759-104759
Open Access | Times Cited: 40
Peptides of a Feather: How Computation Is Taking Peptide Therapeutics under Its Wing
Tom Kazmirchuk, Calvin Bradbury-Jost, Taylor Ann Withey, et al.
Genes (2023) Vol. 14, Iss. 6, pp. 1194-1194
Open Access | Times Cited: 15
An enhanced broad-spectrum peptide inhibits Omicron variants in vivo
Wenwen Bi, Kaiming Tang, Guilin Chen, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101418-101418
Open Access | Times Cited: 6
VIPER: Virus Inhibition Via Peptide Engineering and Receptor Mimicry
A Klingenberg, Dario Ghersi
Journal of Computational Biology (2025)
Closed Access
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
Murat Öz, Dietrich E. Lorke, Nadine Kabbani
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107750-107750
Open Access | Times Cited: 41
Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants
Arpan Acharya, Kabita Pandey, Michellie Thurman, et al.
Journal of Virology (2021) Vol. 95, Iss. 24
Open Access | Times Cited: 34
Treatments for COVID-19: Lessons from 2020 and new therapeutic options
Fanny Salasc, Thomas Lahlali, Emilie Laurent, et al.
Current Opinion in Pharmacology (2021) Vol. 62, pp. 43-59
Open Access | Times Cited: 32
Peptide-based direct electrochemical detection of receptor binding domains of SARS-CoV-2 spike protein in pristine samples
T. H. Vignesh Kumar, Sowmiya Srinivasan, V. Krishnan, et al.
Sensors and Actuators B Chemical (2022) Vol. 377, pp. 133052-133052
Open Access | Times Cited: 23
Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein
Afsaneh Sadremomtaz, Zayana M. Al-Dahmani, Angel J. Ruiz‐Moreno, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2836-2847
Open Access | Times Cited: 31
Secreted Expression of mRNA‐Encoded Truncated ACE2 Variants for SARS‐CoV‐2 via Lipid‐Like Nanoassemblies
Min Li, Sanpeng Li, Yixuan Huang, et al.
Advanced Materials (2021) Vol. 33, Iss. 34
Open Access | Times Cited: 29
SARS-CoV-2 cell entry and targeted antiviral development
Zinuo Chen, Ruikun Du, Jazmin Galván Achi, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 12, pp. 3879-3888
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top